Foresite Capital Management IV as of March 31, 2023
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 8 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 31.4 | $60M | 9.7M | 6.25 | |
| Pharvaris N V (PHVS) | 13.6 | $26M | 3.2M | 8.05 | |
| Lyell Immunopharma (LYEL) | 12.2 | $24M | 10M | 2.36 | |
| Aclaris Therapeutics (ACRS) | 11.8 | $23M | 2.8M | 8.09 | |
| Kura Oncology (KURA) | 11.7 | $23M | 1.8M | 12.23 | |
| Syndax Pharmaceuticals (SNDX) | 9.6 | $19M | 875k | 21.12 | |
| Cymabay Therapeutics | 8.1 | $16M | 1.8M | 8.72 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 1.6 | $3.1M | 1.8M | 1.76 |
